Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Clinical
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint…
Clinical
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Commercial
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
Clinical
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA…
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Home
Clinical
Phase II
Phase II
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II
Galecto Appoints Anne Prener to its Board of Directors
Biospace News
-
January 8, 2021
Phase II
Zydus Cadila submits Phase I/II clinical trial data of ZyCoV-D, seeks nod to start Phase III Clinical Trials – FirstWord Pharma
Phase II
High-Dose Quadrivalent Influenza Vaccine Shows Favourable Phase 2 Trial Results in Children: Presented at ESPID – FirstWord Pharma
Phase II
Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update Nasdaq:IDRA
Phase II
Brazil governor says health regulator will not be pressured over coronavirus vaccine – FirstWord Pharma
Phase II
BerGenBio Virtual R&D Day – 06 November 2020
Biospace News
-
October 23, 2020
0
Phase II
BioSpace Global Roundup, Oct. 22
Biospace News
-
October 22, 2020
0
Phase II
RIBOMIC Announces Dosing of First Subject in RBM-007 Phase 1 Clinical...
Biospace News
-
July 15, 2020
0
Phase II
Tiziana Life Sciences plc Change to ADS Ratio
Biospace News
-
July 15, 2020
0
Phase II
IMV Updates Rapid Progress on COVID-19 Vaccine Program
Biospace News
-
July 14, 2020
0
1
2
3
...
34
Page 1 of 34
- Advertisement -
MOST POPULAR
Antisense Therapeutics Announces Appointment of US-based Consultant Medical Director
February 27, 2020
BW Therapeutics Announces Opening Of Series A Round And Strategic Partnering...
January 10, 2020
BioNTech bolsters T-cell therapy pipeline with Neon buyout
January 16, 2020
Platelet-Rich Plasma Effective Therapy for Preventing Hair Loss: Presented at AAD
March 8, 2019
Load more
HOT NEWS
Commercial
Hansoh Pharma’s Ameile (Almonertinib) Receives Marketing Authorization in China for Second-Line...
Clinical
PharmaMar receives Orphan Drug Designation for lurbinectedin from the Swiss Agency...
Clinical
FDA clears Karyopharm’s nuclear export inhibitor Xpovio for refractory multiple myeloma
Others
Intec Pharma Announces Proposed Public Offering – Jan. 30, 2020
